ESBATech AG: Clinical Trials

3 trials sponsored by ESBATech AG, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 22Completed 2

Follow ESBATech AG: new trials by email

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ocular Biodistribution Study for Topically Applied ESBA105
Placebo - Cataract
Phase 1 / Phase 2CompletedESBATech AG792009-01-012010-09-24
Study of Intra-articular DLX105 Applied to Patients With Severely Painful Osteoarthritis of the Knee
DLX105, a single-chain (scFv) antibody fragment against TNF-alpha, Placebo - Osteoarthritis
Phase 1 / Phase 2CompletedESBATech AG272008-12-012010-09-24
Study of ESBA105 Eye Drops in Healthy Subjects
ESBA105 - Healthy
Phase 1CompletedESBATech AG272008-04-012008-08-25

Conditions studied

Cataract (1)  ·  Macular Edema (1)  ·  Osteoarthritis (1)  ·  Pain (1)

Interventions

ESBA105 (1)

Countries

Switzerland (3)  ·  Germany (1)

Top investigators

Michael A Thiel, MD, PhD (1)  ·  PD.Dr. Diego Kyburz, MD (1)  ·  Prof. Georg Schett, MD (1)